Events

E.g., 11/23/2020
E.g., 11/23/2020

  • Application Deadline: Irving Multi-PI Planning Grant

    Monday, October 12, 2020 to Friday, December 4, 2020
    6:00 PM to 5:00 PM
    TBD TBD
    • Basic Health Sciences
    • Clinical Health Sciences
    • College of Dental Medicine
    • College of Physicians and Surgeons
    • Columbia Nursing
    • Engineering
    • Healthcare
    • Mailman School of Public Health
    • Research
    Applications are now being accepted for the Irving Multi-PI Planning Grant

    The Irving Institute, in conjunction with the Columbia University Clinical Trials Office, Herbert Irving Comprehensive Cancer Center (HICCC), and the Herbert and Florence Irving Institute for Cancer Dynamics, is providing funds ranging from $60,000 – 80,000 each for up to four (4) projects. These pilot funds are intended to support the submission of multi-component biomedical research grants (e.g. SPORE, U54, P01, P50) and large multi-PI research grants (e.g. NCATS U01, MPI grants that require NIH preapproval). Priority will be given to projects proposing to apply for NCATS U01 and SPORE grants.

    Deadline is December 4th, 5:00pm EST

  • Ethical, Legal, and Social Impacts Course

    Wednesday, December 9, 2020
    10:00 AM to 1:00 PM
    Online Event
    • Clinical Health Sciences
    • Research
    • Social Justice
    • Teaching and Learning
    <h3><strong>&quot;Research on the Psychosocial Impacts of Genomic Information: Introduction to Randomized DesignsResearch on the Psychosocial Impacts of Genomic Information: Introduction to Randomized Designs&quot;</strong></h3>

    <p>&nbsp;</p>

    <p><strong><em>Short course co-sponsored by the Irving Institute for Clinical and Translational Research and the Center for Research on Ethical, Legal &amp; Social Implications of Psychiatric, Neurologic &amp; Behavioral Genetics</em></strong></p>

    <p>Among various approaches to patient-oriented research, experimental designs in which participants are randomly assigned to different conditions are often considered the most rigorous. For example, in clinical trials, random assignment of participants to receive alternative treatments is crucial to evaluate treatment efficacy while protecting against false inferences due to extraneous factors (e.g., other differences in traits that influence survival between treated and untreated persons).&nbsp; Experimental designs are also extremely powerful for study of the potential ethical, legal, and social impacts (ELSI) of genetic and genomic information. This short course will provide background about the importance of such designs for ELSI-related research, the types of questions they can address, and the various ways in which they can be implemented.</p>

    <p>&nbsp;</p>

    <p><strong>Course faculty:</strong></p>

    <p><strong>Matthew S. Lebowitz, Ph.D.</strong></p>

    <p>Assistant Professor of Medical Psychology (in Psychiatry), Columbia University</p>

    <p>&nbsp;</p>

    <p><strong>Jo C. Phelan, Ph.D.</strong></p>

    <p>Professor Emerita, Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University</p>

    <p>&nbsp;</p>

    <p><strong>Lawrence H. Yang, Ph.D.</strong></p>

    <p>Associate Professor of Social and Behavioral Sciences, School of Global Public Health, New York University</p>

    <p>&nbsp;</p>

    <p><strong>Ruth Ottman, Ph.D.</strong></p>

    <p>Professor of Epidemiology (in Neurology and the Sergievsky Center), and Deputy Director, Center for Research on Ethical, Legal &amp; Social Implications of Psychiatric, Neurologic &amp; Behavioral Genetics, Columbia University</p>